BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7788929)

  • 1. Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide.
    Lildholdt T; Rundcrantz H; Lindqvist N
    Clin Otolaryngol Allied Sci; 1995 Feb; 20(1):26-30. PubMed ID: 7788929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucocorticoid treatment for nasal polyps. The use of topical budesonide powder, intramuscular betamethasone, and surgical treatment.
    Lildholdt T; Rundcrantz H; Bende M; Larsen K
    Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):595-600. PubMed ID: 9193219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an aqueous and a powder formulation of nasal budesonide compared in patients with nasal polyps.
    Tos M; Svendstrup F; Arndal H; Orntoft S; Jakobsen J; Borum P; Schrewelius C; Larsen PL; Clement F; Barfoed C; Rømeling F; Tvermosegaard T
    Am J Rhinol; 1998; 12(3):183-9. PubMed ID: 9653476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps.
    Vendelo Johansen L; Illum P; Kristensen S; Winther L; Vang Petersen S; Synnerstad B
    Clin Otolaryngol Allied Sci; 1993 Dec; 18(6):524-7. PubMed ID: 8877234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of intranasal budesonide with placebo for nasal polyposis.
    Ruhno J; Andersson B; Denburg J; Anderson M; Hitch D; Lapp P; Vanzieleghem M; Dolovich J
    J Allergy Clin Immunol; 1990 Dec; 86(6 Pt 1):946-53. PubMed ID: 2262649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry powder inhalation of budesonide in allergic rhinitis.
    Andersson M; Lindqvist N; Svensson C; Ek L; Pipkorn U
    Clin Otolaryngol Allied Sci; 1993 Feb; 18(1):30-3. PubMed ID: 8448887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide powder administration for the treatment of grass-pollen-induced allergic rhinitis.
    Pedersen B; Larsen BB; Dahl R; Hedbys L; Mygind N
    Allergy; 1994 Dec; 49(10):855-60. PubMed ID: 7709995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis.
    Pedersen B; Bundgaard Larsen B; Dahl R; Lindqvist N; Mygind N
    Allergy; 1991 Nov; 46(8):582-7. PubMed ID: 1789399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budesonide in the treatment of nasal polyposis.
    Holopainen E; Grahne B; Malmberg H; Mäkinien J; Lindqvist N
    Eur J Respir Dis Suppl; 1982; 122():221-8. PubMed ID: 6958488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of allergy in the therapeutic response of nasal polyps.
    Kirtsreesakul V
    Asian Pac J Allergy Immunol; 2002 Sep; 20(3):141-6. PubMed ID: 12587836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis.
    Andersson M; Berglund R; Greiff L; Hammarlund A; Hedbys L; Malcus I; Nilsson P; Olsson P; Sjölin IL; Synnerstad B
    Rhinology; 1995 Mar; 33(1):18-21. PubMed ID: 7784789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of a new grading system for studying nasal polyps with the potential to detect early changes in polyp size after treatment with a topical corticosteroid (budesonide).
    Johansson L; Holmberg K; Melén I; Stierna P; Bende M
    Acta Otolaryngol; 2002 Jan; 122(1):49-53. PubMed ID: 11876598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis.
    Filiaci F; Passali D; Puxeddu R; Schrewelius C
    Rhinology; 2000 Dec; 38(4):185-90. PubMed ID: 11190754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal powder administration of budesonide for seasonal rhinitis in children and adolescents.
    Agertoft L; Wolthers OD; Fuglsang G; Pedersen S
    Pediatr Allergy Immunol; 1993 Aug; 4(3):152-6. PubMed ID: 8220803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide nasal spray as prophylactic treatment after polypectomy (a double blind clinical trial).
    Hartwig S; Lindén M; Laurent C; Vargö AK; Lindqvist N
    J Laryngol Otol; 1988 Feb; 102(2):148-51. PubMed ID: 3279143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasal polyp inflammation. Effect of topical nasal steroid.
    Kanai N; Denburg J; Jordana M; Dolovich J
    Am J Respir Crit Care Med; 1994 Oct; 150(4):1094-100. PubMed ID: 7921442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical corticosteroids and nasal reactivity.
    Wihl JA
    Eur J Respir Dis Suppl; 1982; 122():205-10. PubMed ID: 6958486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between intranasal budesonide aerosol and budesonide dry powder in the treatment of hay fever symptoms.
    Malmberg H; Holopainen E; Simola M; Böss I; Lindqvist N
    Rhinology; 1991 Jun; 29(2):137-41. PubMed ID: 1891681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.